PT931264E - Metodo de diagnostico da aterosclerose - Google Patents
Metodo de diagnostico da ateroscleroseInfo
- Publication number
- PT931264E PT931264E PT97939603T PT97939603T PT931264E PT 931264 E PT931264 E PT 931264E PT 97939603 T PT97939603 T PT 97939603T PT 97939603 T PT97939603 T PT 97939603T PT 931264 E PT931264 E PT 931264E
- Authority
- PT
- Portugal
- Prior art keywords
- diagnostic method
- aterosclerosis
- level
- chlorotyrosine
- atherosclerosis
- Prior art date
Links
- 238000002405 diagnostic procedure Methods 0.000 title abstract 2
- ACWBBAGYTKWBCD-ZETCQYMHSA-N 3-chloro-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(Cl)=C1 ACWBBAGYTKWBCD-ZETCQYMHSA-N 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000001539 phagocyte Anatomy 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/709,916 US6268220B1 (en) | 1996-09-09 | 1996-09-09 | Diagnostic method for atherosclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT931264E true PT931264E (pt) | 2002-08-30 |
Family
ID=24851820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97939603T PT931264E (pt) | 1996-09-09 | 1997-09-03 | Metodo de diagnostico da aterosclerose |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6268220B1 (pt) |
| EP (1) | EP0931264B1 (pt) |
| JP (1) | JP3553611B2 (pt) |
| AT (1) | ATE216495T1 (pt) |
| AU (1) | AU4165197A (pt) |
| CA (1) | CA2264757C (pt) |
| DE (1) | DE69712079T2 (pt) |
| DK (1) | DK0931264T3 (pt) |
| ES (1) | ES2175453T3 (pt) |
| PT (1) | PT931264E (pt) |
| WO (1) | WO1998010294A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306576B1 (en) | 1999-02-19 | 2001-10-23 | Cleveland Clinic Foundation | Diagnostic methods for asthma |
| US6548252B1 (en) * | 2000-10-13 | 2003-04-15 | Esa, Inc. | Detection of DNA damage |
| US7780950B2 (en) * | 2002-01-02 | 2010-08-24 | The Cleveland Clinic Foundation | Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents |
| DK1353666T3 (da) * | 2001-01-02 | 2013-10-14 | Cleveland Clinic Foundation | Myeloperoxidase, en risikoindikator for cardiovasculær sygdom |
| EP1385990A4 (en) * | 2001-05-09 | 2004-09-22 | Insight Biopharmaceuticals Ltd | METHODS AND MATERIALS USING HEPARANASE AS A DIAGNOSTIC MARKER FOR HEMOSTATIC DISORDERS |
| US6939716B2 (en) * | 2001-09-19 | 2005-09-06 | Washington University | Method for detecting conditions indicative of sepsis |
| WO2004003555A1 (en) | 2002-07-01 | 2004-01-08 | University Of Rochester Medical Center | Method for determination of likelihood of occurrence of preterm labor in pregnant females |
| US7459286B1 (en) | 2003-10-22 | 2008-12-02 | The Cleveland Clinic Foundation | Assessing the risk of a major adverse cardiac event in patients with chest pain |
| ES2381551T3 (es) | 2003-12-05 | 2012-05-29 | The Cleveland Clinic Foundation | Marcadores de riesgo para enfermedad cardiovascular |
| EP1787116A4 (en) * | 2004-07-19 | 2008-05-28 | Univ Washington | METHOD FOR ASSESSING THE RISK OF DEVELOPING A CARDIOVASCULAR DISEASE |
| WO2006020498A2 (en) | 2004-08-11 | 2006-02-23 | The Cleveland Clinic Foundation | Therapeutic agents and methods for cardiovascular disease |
| DE102004042530B4 (de) * | 2004-09-02 | 2006-10-19 | Mosaiques Diagnostics And Therapeutics Ag | Verfahren zur Diagnose von Arteriosklerose |
| US8241861B1 (en) | 2008-07-08 | 2012-08-14 | Insilicos, Llc | Methods and compositions for diagnosis or prognosis of cardiovascular disease |
| US9546220B2 (en) | 2010-10-19 | 2017-01-17 | Battelle Memorial Institute | Compositions, antibodies, asthma diagnosis methods, and methods for preparing antibodies |
| US10734216B2 (en) | 2015-05-11 | 2020-08-04 | The University Of North Carolina At Chapel Hill | Pressure driven fluidic injection for chemical separations by electrophoresis |
| US9606082B2 (en) | 2015-05-11 | 2017-03-28 | The University Of North Carolina At Chapel Hill | Pressure driven microfluidic injection for chemical separations |
| US9728387B2 (en) | 2015-10-20 | 2017-08-08 | The University Of North Carolina At Chapel Hill | Solid phase extraction with capillary electrophoresis |
-
1996
- 1996-09-09 US US08/709,916 patent/US6268220B1/en not_active Expired - Fee Related
-
1997
- 1997-09-03 EP EP97939603A patent/EP0931264B1/en not_active Expired - Lifetime
- 1997-09-03 AU AU41651/97A patent/AU4165197A/en not_active Abandoned
- 1997-09-03 ES ES97939603T patent/ES2175453T3/es not_active Expired - Lifetime
- 1997-09-03 DK DK97939603T patent/DK0931264T3/da active
- 1997-09-03 WO PCT/US1997/015114 patent/WO1998010294A1/en not_active Ceased
- 1997-09-03 CA CA002264757A patent/CA2264757C/en not_active Expired - Fee Related
- 1997-09-03 JP JP51273898A patent/JP3553611B2/ja not_active Expired - Fee Related
- 1997-09-03 PT PT97939603T patent/PT931264E/pt unknown
- 1997-09-03 AT AT97939603T patent/ATE216495T1/de not_active IP Right Cessation
- 1997-09-03 DE DE69712079T patent/DE69712079T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998010294A1 (en) | 1998-03-12 |
| EP0931264A1 (en) | 1999-07-28 |
| US6268220B1 (en) | 2001-07-31 |
| ATE216495T1 (de) | 2002-05-15 |
| DK0931264T3 (da) | 2002-08-05 |
| JP2001500257A (ja) | 2001-01-09 |
| CA2264757A1 (en) | 1998-03-12 |
| DE69712079T2 (de) | 2002-10-02 |
| CA2264757C (en) | 2005-10-04 |
| AU4165197A (en) | 1998-03-26 |
| ES2175453T3 (es) | 2002-11-16 |
| EP0931264B1 (en) | 2002-04-17 |
| JP3553611B2 (ja) | 2004-08-11 |
| DE69712079D1 (de) | 2002-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT931264E (pt) | Metodo de diagnostico da aterosclerose | |
| PT931265E (pt) | Metodo de diagnostico da aterosclerose | |
| NO971348D0 (no) | Pröveenhet for oppsamling og undersökelse av kroppsvæske | |
| DE69635174D1 (de) | Nichtinvasive Vorrichtung zur Blutuntersuchung | |
| AU1726797A (en) | A method for monitoring the health of a patient by measuring and predicting the glucose level of the patient's blood sample | |
| DE69623628D1 (de) | Virtuelles medizinisches instrument zum medizinischen diagnostiktesten von patienten | |
| AU8160598A (en) | Diagnostic complex for measurement of the condition of biological tissues and liquids | |
| DE69531743D1 (de) | System und verfahren zur diagnose von krankheiten an lebendem gewebe | |
| DE69736527D1 (de) | Messvorrichtung zur schnellen nichtinvasiven blutdruckbestimmung | |
| BR9611423A (pt) | Peça manual de instrumento cirúrgico e sistema | |
| FI952131A7 (fi) | Analyysijärjestelmä potilaan verestä analysoitavan aineen tarkkailemiseksi | |
| AU1364292A (en) | Non-invasive device and method for determining concentrations of various components of blood or tissue | |
| FR2753897B1 (fr) | Dispositif pour le diagnostic endoscopique photodynamique de tissu tumoral | |
| DE69601544D1 (de) | Harnsammel und Untersuchungsvorrichtung, und Gebrauchsverfahren | |
| FI963893A7 (fi) | Kertakäyttölaite kehollisen nesteen kokoamista ja mahdollista analysointia varten | |
| EP0924523A3 (de) | Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen | |
| HU9202178D0 (en) | Method for detecting irregularities of bone and other connective tissues in human beings and in animals | |
| SE9401883L (sv) | Sätt vid diagnosticering av födoämnesintolerans/allergi samt instrument för diagnostiseringen | |
| EP0886142A4 (en) | METHOD FOR DETERMINING ANTI-GADII ANTIBODIES AND METHOD FOR DIAGNOSING CANCER | |
| AU4756396A (en) | Medical probe device with scope and proximal aspiraton openings and method for treatment of the prostate with same | |
| ZA98665B (en) | Method and apparatus for the measurement of blood coagulation properties with absorbent materials | |
| DE68911574D1 (de) | Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür. | |
| WO1992005278A3 (en) | Method for the determination of the differential expression of mrna for the amyloid precursor protein (app) | |
| ATE220458T1 (de) | Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten | |
| FI953364A0 (fi) | Kehon nesteistä tai kudoksista uutettujen synteettisten oligonukleotidien toteaminen |